Hassan Esraa Mamdouh, Mushtaq Hisham, Mahmoud Esraa Elaraby, Chhibber Sherley, Saleem Shoaib, Issa Ahmed, Nitesh Jain, Jama Abbas B, Khedr Anwar, Boike Sydney, Mir Mikael, Attallah Noura, Surani Salim, Khan Syed A
Critical Care Medicine, Mayo Clinic Health System, Mankato, MN 56001, United States.
Medicine, St. Vincent's Medical Center, Bridgeport, CT 06606, United States.
World J Clin Cases. 2022 Nov 16;10(32):11702-11711. doi: 10.12998/wjcc.v10.i32.11702.
Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemia state (HHS) are two life-threatening metabolic complications of diabetes that significantly increase mortality and morbidity. Despite major advances, reaching a uniform consensus regarding the diagnostic criteria and treatment of both conditions has been challenging. A significant overlap between these two extremes of the hyperglycemic crisis spectrum poses an additional hurdle. It has well been noted that a complete biochemical and clinical patient evaluation with timely diagnosis and treatment is vital for symptom resolution. Worldwide, there is a lack of large-scale studies that help define how hyperglycemic crises should be managed. This article will provide a comprehensive review of the pathophysiology, diagnosis, and management of DKA-HHS overlap.
糖尿病酮症酸中毒(DKA)和高渗高血糖状态(HHS)是糖尿病两种危及生命的代谢并发症,会显著增加死亡率和发病率。尽管取得了重大进展,但就这两种病症的诊断标准和治疗达成统一共识一直具有挑战性。高血糖危象谱这两个极端情况之间存在显著重叠,这又增加了一道障碍。人们已经充分认识到,对患者进行全面的生化和临床评估并及时诊断和治疗对于症状缓解至关重要。在全球范围内,缺乏有助于明确如何管理高血糖危象的大规模研究。本文将对DKA-HHS重叠的病理生理学、诊断和管理进行全面综述。